Progyny, Inc.
A maker of employer-sponsored fertility and women's health benefits, Progyny bundles treatment into "Smart Cycles" supported by its Progyny Rx pharmacy and a national network of fertility specialists, serving large self-insured employers and their families. Founded in New York in 2008 as a medical-device startup (Auxogen Bioscience) that built an embryo-testing tool, it pivoted to benefits in 2015 and adopted its name—a playful twist on "progeny" (meaning offspring)—to reflect its mission of helping people build families. Progyny has since expanded into pregnancy, postpartum, menopause, and family-wellbeing support.
Sold 18.1K
Granted 19.5K · Bought 76.9K · Sold 95.0K
Sold 10.07M
Sold 4.00M
Sold 3.65M
Granted 754.5K · Sold 384.0K
Granted 2.54M · Bought 289.0K · Sold 3.87M
Granted 296.3K · Sold 2.67M
Granted 264.0K · Sold 58.7K
Granted 5.37M · Bought 150.0K · Sold 6.30M
Granted 297.2K · Sold 121.5K
Granted 126.1K · Sold 17.6K
Granted 415.5K · Sold 174.5K
Granted 87.1K · Sold 9.6K
Granted 48.1K · Sold 1.5K
Granted 33.7K · Sold 11.9K
Granted 34.0K
Granted 45.9K · Sold 15.6K
Granted 28.7K
Granted 23.6K
Granted 16.7K
Granted 80.5K · Sold 36.8K
Granted 5.7K
Granted 5.7K
Granted 2.2K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Kleiner Perkins Caufield & Byers Xiii, LLC +1 co-filer10% owner · 27 transactions | — | 89.14Mas of Jun 2021 | — | — | 18.1K |
| Seidenberg Beth CDirector · 65 transactions | — | 22.48Mas of May 2024 | 19.5K | 76.9K | 95.0K |
| Bonderman David +2 co-filers10% owner · 164 transactions | — | 10.00Mas of Jul 2021 | — | — | 10.07M |
| Glaxosmithkline PLC10% owner · 2 transactions | — | 6.66Mas of May 2020 | — | — | 4.00M |
| Bonderman David +3 co-filersFormer 10% Owner · 2 transactions | — | 6.35Mas of Aug 2023 | — | — | 3.65M |
| Ajmani KarinEVP, Chief of Strategic Dev. · 5 transactions | — | 1.13Mas of Feb 2020 | 754.5K | — | 384.0K |
| Anevski PeterCHIEF EXECUTIVE OFFICER, Director · 420 transactions | — | 811.5K | 2.54M | 289.0K | 3.87M |
| Payson NormanDirector · 743 transactions | — | 588.7K | 296.3K | — | 2.67M |
| Sturmer Michael EPRESIDENT · 44 transactions | — | 255.2K | 264.0K | — | 58.7K |
| Schlanger David JExecutive Chairman, Director · 390 transactions | — | 238.5K | 5.37M | 150.0K | 6.30M |
| Bealer JenniferEVP, GENERAL COUNSEL · 106 transactions | — | 103.2Kas of May 2022 | 297.2K | — | 121.5K |
| Swartz AllisonEVP, GC · 34 transactions | — | 82.4K | 126.1K | — | 17.6K |
| Livingston Mark S.CHIEF FINANCIAL OFFICER · 112 transactions | — | 75.3K | 415.5K | — | 174.5K |
| Cummings Melissa BChief Operating Officer · 4 transactions | — | 73.4K | 87.1K | — | 9.6K |
| Clapp GeoffreyChief Product Officer · 6 transactions | — | 59.8K | 48.1K | — | 1.5K |
| Gordon Kevin KDirector · 13 transactions | — | 56.1K | 33.7K | — | 11.9K |
| Park Jeffrey GDirector · 6 transactions | — | 40.0K | 34.0K | — | — |
| Scott CherylDirector · 17 transactions | — | 34.4K | 45.9K | — | 15.6K |
| Holstein Roger CDirector · 6 transactions | — | 28.7K | 28.7K | — | — |
| Dean Lloyd HDirector · 4 transactions | — | 26.5K | 23.6K | — | — |
| Cohen Fred EDirector · 4 transactions | — | 22.7Kas of May 2024 | 16.7K | — | — |
| Greenbaum LisaEVP, Chief Client Officer · 47 transactions | — | 11.7Kas of Apr 2021 | 80.5K | — | 36.8K |
| Bierbower Elizabeth DDirector · 1 transaction | — | 5.7K | 5.7K | — | — |
| Morris Debra LDirector · 1 transaction | — | 5.7K | 5.7K | — | — |
| Clinton MalissiaDirector · 1 transaction | — | 2.2Kas of Oct 2021 | 2.2K | — | — |
| KPCB XIII Associates, LLC10% owner · 1 transaction | — | 0as of Mar 2021 | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -30.99M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.